Secondary Hyperparathyroidism Impacts Antiresorptive TherapySecondary Hyperparathyroidism Impacts Antiresorptive Therapy

Can higher PTH levels negatively influence the therapeutic efficacy of bisphosphonates for osteoporosis? BMC Musculoskeletal Disorders
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Orthopaedics Journal Article Source Type: news